Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder

Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder

Dec 14, 2012
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0